A*STAR Bioinformatics Institute (A*STAR BII)

A new algorithm, BANKSY, expands our understanding of cellular diversity by revealing how cells are influenced by interactions with their neighbours.

A*STAR researchers develop new tools to speed up the development of potent enzymes for oxidising complex alcohol molecules, providing more options for a challenging synthesis step in sustainable chemical manufacturing.

A*STAR researchers discovered a potential new treatment for severe eczema by targeting a protein that regulates immune cell activity.

Antibodies in mucous membranes may be key in protecting against SARS-CoV-2 variants, pointing to the need for COVID-19 vaccines that target these antibody responses.

A high-resolution study of SARS-CoV-2 antibodies revealed how they neutralise variants and reduce the impact of spike protein mutations.

A new machine learning model identifies key dementia features from complex clinical datasets, potentially making diagnoses faster and less subjective.

Innovative designer molecules called stapled peptides effectively target and block cancer processes, promising a new therapeutic approach.

High-resolution simulations uncover dynamic regions on the surface of dengue-like viruses to guide the design of novel antivirals.

Using artificial intelligence techniques, Mai Chan Lau maps the spatial relationships between tumour cells and immune cells to understand their effect on clinical outcomes.

A*STAR frontiers in the national push for a quantum computing advantage

Smartwatch data points to a connection between physical activity and prolonged COVID-19 symptoms among healthcare workers.

Through innovative technologies and deep biological insights, A*STAR research institutes and ecosystem partners aim to enhance the healthspan of Asia’s ageing populations.